- Filed
- Jan 13, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2025 · Jan 13, 2025 | 19.77M sh |
| Cash And Equivalents | Q2 2025 · Nov 30, 2024 | $165 |
| Cash And Equivalents | Q2 2025 · May 31, 2024 | $14 |
| Current Liabilities | Q2 2025 · Nov 30, 2024 | $2.41M |
| Current Liabilities | Q2 2025 · May 31, 2024 | $2.4M |
| Total Liabilities | Q2 2025 · Nov 30, 2024 | $2.41M |
| Total Liabilities | Q2 2025 · May 31, 2024 | $2.4M |
| Current Assets | Q2 2025 · Nov 30, 2024 | $165 |
| Current Assets | Q2 2025 · May 31, 2024 | $14 |
| Total Assets | Q2 2025 · Nov 30, 2024 | $165 |
| Total Assets | Q2 2025 · May 31, 2024 | $14 |
| Shares Diluted | Q2 2025 · Nov 30, 2023 | 19.77M sh |
| Shares Diluted | Q2 2025 · Nov 30, 2023 | 19.77M sh |
| Operating Cash Flow restated | Q2 2025 · Nov 30, 2023 | −$16.4K |
| Stockholders Equity | Q2 2025 · Nov 30, 2023 | −$2.38M |
| Stockholders Equity | Q2 2025 · Aug 31, 2023 | −$2.34M |
| Stockholders Equity | Q2 2025 · May 31, 2023 | −$2.3M |
| Eps Diluted | Q2 2025 · Nov 30, 2023 | $0.00 |
| Eps Diluted | Q2 2025 · Nov 30, 2023 | $0.00 |
| Eps Basic | Q2 2025 · Nov 30, 2023 | $0.00 |
| Eps Basic | Q2 2025 · Nov 30, 2023 | $0.00 |
| Sga Expense | Q2 2025 · Nov 30, 2023 | $8.49K |
| Sga Expense | Q2 2025 · Nov 30, 2023 | $10.18K |
| Rd Expense | Q2 2025 · Nov 30, 2023 | $2.18K |
| Rd Expense | Q2 2025 · Nov 30, 2023 | $3.7K |
| Net Income | Q2 2025 · Nov 30, 2023 | −$45.11K |
| Net Income | Q2 2025 · Nov 30, 2023 | −$86.03K |
| Operating Income | Q2 2025 · Nov 30, 2023 | −$45.11K |
| Operating Income | Q2 2025 · Nov 30, 2023 | −$86.03K |
| Revenue | Q2 2025 · Nov 30, 2023 | $0 |
| Revenue | Q2 2025 · Nov 30, 2023 | $0 |